Psychedelic biotech stocks are currently riding a wave of excitement and speculation, but that excitement isn't backed by solid, proven business results. When a major event happens — like an FDA decision or clinical trial results — the stock price tends to react violently, swinging wildly up or down in a single trading day. This kind of volatility can mean big gains or devastating losses for investors very quickly.
Rally is anticipatory and thin-float. No de-risked fundamentals support current levels. Binary events resolve sentiment violently in both directions.